Drugs targeting influenza virus neuraminidase

摘要

Influenza viruses cause recurrent pandemics and epidemics in man. The two membrane surface glycoproteins of the virus, the haemagglutinin (reviewed in (1)) and the neuraminidase (reviewed in (2)), undergo continuous antigenic variation, rendering antibodies raised during a prior infection ineffective in preventing infection by current strains.